ORACLE test enhances prediction of lung cancer outcomes

A new test, developed by researchers from UCL Cancer Institute and the Francis Crick Institute, can better predict lung cancer survival at the point of diagnosis, which could inform treatment decisions and potentially reduce the risk of the cancer returning or spreading.

In research published in Nature Cancer, the team assessed the diagnostic test, called ORACLE, in 158 people with lung cancer as part of the Cancer Research UK-funded TRACERx study. They found that ORACLE,…